M
Maravai LifeSciences Holdings D
D
MRVI
3.68000
USD
0.07
(1.94%)
Market Closed
Volume
145,460
EPS
-0
Div Yield
-
P/E
-4
Market Cap
538,690,036
Title: Maravai LifeSciences Holdings
Sector: Healthcare
Industry: Biotechnology
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.







